Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the USA / NCT07862829
Recruiting Observational

Integration of the Oura Ring and Maven Clinic Among Women Who Are Trying to Conceive

NCT07862829 · tracked via the Priya Life Science USA tracker
Sponsor
Ouraring Inc
Phase
Observational
Started
2026-07-29
Last updated
2026-10-07

Condition(s) studied

Trying to Conceive

Study summary

This study aims to characterize Oura Ring users who are trying to conceive. It also evaluates the feasibility and clinical outcomes of integrating Oura data with Maven's clinical support platform.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: 18-45 years old Female sex at birth Currently trying to conceive Able to provide consent electronically Have an Oura Ring (Gen 3 or newer) with an active account Can communicate and provide consent using written and spoken English Lives in the US Exclusion Criteria: Currently using hormonal contraceptives Currently pregnant

Primary outcome measure(s)

  • Primary Outcome Measure — Up to 12 months
    To describe users who are trying to conceive with the use of Maven and/or the Oura Ring, including their health characteristics, knowledge on trying to conceive, stage along their conception journey, reproductive history and behaviors, and engagement with health resources.

Trial sites (1)

FacilityCityRegionStatus
Maven Clinic New York New York Recruiting

More Ouraring Inc. trials in the USA

Oura Ring OA15 Validation Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07862829 on ClinicalTrials.gov ↗ ← All trials in the USA